Zhende Medical Co., Ltd. Class A

Zhende Medical Co., Ltd. Class A

SSSE:603301
82.00
CNY
-1.00
(-1.20%)
1.13EPS
67.86P/E
19.84BMarket Cap
Apr 28Next Earn
Zhende Medical Co., Ltd. Class A
SSE:603301
(Shanghai Stock Exchange)

Recent

price

82.00

P/E

ratio

67.86

div

yld

0.51%

ROIC.AI

2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
26.6
5.21
7.07
8.87
7.92
9.52
50.98
22.56
25.91
15.39
16.05
16.43
17.49
Revenue per Share
0.59
0.4
0.57
0.83
0.72
0.8
12.5
2.64
2.87
0.74
1.45
0.99
1.11
Basic EPS, GAAP
- -
0.61
-0.14
0.32
-1.14
-0.39
9.94
0.54
2.08
-0.55
-1.16
-0.04
- -
Free Cash Flow per Basic Share
1.62
0.19
0.15
0.14
0.12
0.3
0.38
2.46
0.69
1.58
0.6
0.76
0.41
Dividend per Share
2.67
1.97
2.98
3.8
5.73
6.93
18.41
17.9
20.79
20.14
21.18
21.39
21.76
Book Value per Share
0.29
1.14
2.21
3.06
4.89
5.53
16.84
14.19
16.89
14.9
15.52
14.72
15.22
Tangible Book Value per Share
37
196
146
147
180
196
204
226
237
268
266
263
266
Basic Weighted Avg Shares
987
1,021
1,035
1,306
1,429
1,868
10,399
5,092
6,138
4,127
4,264
4,330
4,655
Sales/Revenue/Turnover
6.69
9.63
9.61
13.49
12.66
12.65
36.06
16.76
16.03
10.77
10.18
8.97
9.63
Operating Margin (%)
- -
41
48
59
62
65
79
142
194
243
247
297
- -
Depreciation Expense
22
79
83
122
130
157
2,549
596
680
198
385
261
295
Net Income, GAAP
9.51
13.2
16.81
17.13
14.3
11.37
15.88
12.07
12.47
2.51
16.46
17.77
15.47
Effective Tax Rate (%)
2.21
7.74
8
9.32
9.11
8.4
24.52
11.7
11.08
4.81
9.03
6.02
6.33
Profit Margin (%)
-371
-251
-114
-87
353
796
2,596
1,593
2,615
1,548
1,490
1,051
1,295
Working Capital
48
- -
31
17
1
422
131
178
425
239
285
392
414
LT Debt
106
262
438
560
1,125
1,400
4,467
4,440
5,756
5,604
5,896
5,962
6,004
Total Equity
- -
9.65
8.4
13.26
10.57
9.86
81.14
13.76
12.18
3.5
6.5
3.95
4.11
Return on Invested Capital (%)
- -
15.71
13.5
15.15
12.05
8.8
60.54
9.62
11.84
3.39
6.29
4.1
4.25
Return on Capital (%)
- -
44.2
23.8
24.43
15.47
12.64
92.01
14.45
14.15
3.64
7
4.6
5.18
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
ST Debt
875
916
1,005
LT Borrowings
381
382
384
LT Finance Leases
32
30
31
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
264
264
264
Market Capitalization
26,197
22,999
19,836

Working Capital

CNY

•

in mil. unless spec.
Mar'26
Jun'26
Sep'26
Total Current Assets
2,822
2,905
3,139
Cash, Cash Equivalents & STI
1,069
961
1,059
Accounts Receivable, Net
614
766
794
Inventories
831
899
902
Total Current Liabilities
1,717
1,751
1,844
Payables & Accruals
- -
- -
- -
ST Debt
875
916
1,005
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
47.19%
6.55%
1.12%
Free Cash Flow
-372.3%
18.46%
-96.2%
Net Income, GAAP
153.27%
-14.3%
-32.29%
Sales/Revenue/Turnover
46.6%
-11.68%
1.54%
Total Cash Common Dividend
82.53%
132.17%
26.41%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
964
1,079
1,083
1,138
4,264
2025
992
1,109
- -
1,145
4,330
2026
1,000
1,224
1,286
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.28
0.33
0.55
0.29
1.45
2025
0.19
0.29
- -
0.22
0.99
2026
0.2
0.34
0.35
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.03
0.03
0.51
0.03
0.6
2025
0.01
0.68
- -
0.04
0.76
2026
0.02
0.34
0.01
- -
- -
Business
Zhende Medical Co., Ltd. Zhende Medical Co., Ltd. (603301.SS) is a China-based company principally engaged in the research, development, production, and sales of medical dressings and related healthcare products; its core offerings encompass modern wound care products including advanced dressings, stoma care solutions, and bioactive materials; traditional wound care items such as gauze swabs, bandages, non-woven swabs, and lap sponges; pressure treatment and fixation products like compression wraps and immobilization devices; surgical infection management solutions including surgical drapes, gowns, and infection control kits; sensory control protection and incontinence care products; as well as medical-grade personal care, home health care, and sports protection items. Founded in 1993 and headquartered in Shaoxing City, Zhejiang Province, the company operates five manufacturing bases across Zhejiang, Henan, Jiangsu, Anhui, and Shanghai, with distribution networks covering 31 provinces in China and exports to over 73 countries primarily in Europe and North America, serving nearly 10,000 hospitals, health systems, and over 40,000 pharmacies. Zhende Medical holds certifications including FDA, CE, ISO 13485, and CFDA, positioning it as a market leader in infection control, compression therapy, and wound care segments in China. Recent developments include the April 2023 acquisition of Jiangsu Embrace Science & Technology Development Co., Ltd. to expand prefilled syringe and related product capabilities; a March 2025 stake transaction where Sun Jimu acquired a 5% interest from Zhejiang Zhende Holding Co., Ltd.; property sale announced in September 2024 for 298 million yuan to optimize assets; and participation in the 2025 China International Medical Equipment Fair (CMEF) to showcase next-generation innovations in pressure testing and medical solutions.